METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric field therapy shows promise for tough pancreatic cancer
Disease control CompletedThis study tested a wearable device that creates electric fields (TTFields) combined with three drugs (atezolizumab, gemcitabine, nab-paclitaxel) in 84 people with metastatic pancreatic cancer who had not received prior treatment. The goal was to see if this combination could con…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: NovoCure Ltd. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for hard-to-treat gut cancers: targeted combo tested
Disease control CompletedThis study tested a new drug called ERAS-007 combined with other cancer treatments in 101 people with advanced colorectal or pancreatic cancer that had spread. The main goals were to find the safest dose and check for side effects. The approach targets a specific cell pathway (MA…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated May 04, 2026 16:18 UTC